Study S001705

Tirzepatide for Treatment of CCCA

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07734870
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: RECRUITING
Enrollment: 20
Start: 2026-09-15
Primary completion: 2028-05-25
Lead sponsor: Johns Hopkins University
Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in Central Centrifugal Cicatricial Alopecia Clinical Activity Tool Score [Baseline, 3 months, 6 months]
Change in Scalp Gene-Expression Profiles [Baseline, 6 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0018381	Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. Loomba R, The New England journal of medicine	2024	Randomized trial	PMID 38856224 DOI	registry reference BACKGROUND:38856224